eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Reckitt Benckiser Healthcare (UK) Ltd

Freepost, RSBU-TEBT-GSTU, Reckitt Benckiser, Kingston Upon Thames, KT2 6LZ, UK
Telephone: +44 (0)500 455 456
WWW: http://www.reckittbenckiser.com
Medical Information Direct Line: +44 (0)500 455 456
Customer Care direct line: +44 (0)500 455 456

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 07/03/2011
SPC Dettol Antiseptic Cream


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Dettol Antiseptic Cream


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredient

% w/w

Specification

Chloroxylenol

0.30

BP

Triclosan

0.30

USP

Edetic acid**

0.20

EP

**Added as the approximate tri-potassium salt by reaction with 0.142% w/w potassium carbonate.


Go to top of the page
3. PHARMACEUTICAL FORM

Topical cream


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For application to the skin for use in cuts, bites, stings, abrasions, and for use as an antiseptic hand cream.


Go to top of the page
4.2 Posology and method of administration

For topical application to the skin.

Adults and children: Apply in small amounts directly on the skin as required. For cuts and grazes, clean the wound and surrounding skin by wiping gently with Dettol Cream, preferably on a piece of lint or cotton wool. For continued protection apply Dettol Antiseptic Cream again. If necessary, cover the injury with a clean dressing.

There is no indication that dosage need be modified for the elderly.


Go to top of the page
4.3 Contraindications

Allergic skin reactions, dermatitis, eczema or other skin complaints.


Go to top of the page
4.4 Special warnings and precautions for use

Treatment should be terminated if irritation develops. In the event of any irritation of sensitive skin, wash with lukewarm water.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

There is inadequate evidence of the safety of the drug in human pregnancy and lactation, but there has been wide use in humans without apparent ill consequence. Animal studies have shown no hazard. If drug therapy is needed in pregnancy this drug can be used if there is no safer alternative.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

None known.


Go to top of the page
4.9 Overdose

It is unlikely that a sufficient volume of the cream could be ingested to cause any medical problems. In the event of accidental eye contact, wash with luke warm water.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Chloroxylenol is an antiseptic agent whose activity is principally against Streptococci, but also has some activity against Staphylococci. Triclosan exhibits bacteriostatic activity against a wide range of Gram positive and Gram negative organisms. These active ingredients are themselves resistant to the Pseudomonas species, but inclusion of EDTA potentiates their activity against this organism.


Go to top of the page
5.2 Pharmacokinetic properties

Animal studies have shown that following dermal application chloroxylenol is rapidly absorbed (Cmax = 1-2 hours), extensively metabolised and excreted via the kidney with almost complete elimination within 24 hours. In man, similar application of triclosan resulted in only minimal percutaneous absorption (around 5%) following 24 hour occlusion to the skin. Subsequent metabolism occurs slowly (T½ = 10 hours), followed by rapid urinary excretion, principally as the glucuronide.


Go to top of the page
5.3 Preclinical safety data

No preclinical findings of relevance have been reported.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Emulsifying wax

Carbomer

Glycerol

Almond oil

Terpineol

Perfume ES9078

Potassium hydroxide solution 50%

Purified water


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

Three years.


Go to top of the page
6.4 Special precautions for storage

None.


Go to top of the page
6.5 Nature and contents of container

Collapsible aluminium tube with an internal lacquer coating.

Pack size: 30g & 50g.


Go to top of the page
6.6 Special precautions for disposal and other handling

For topical application to the skin.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Reckitt Benckiser (UK) Limited

103-105 Bath Road

Slough, SL1 3UH

United Kingdom


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 19718/0001


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

04/11/2002 / 14/07/2003


Go to top of the page
10. DATE OF REVISION OF THE TEXT

22/11/2010



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/23369/SPC/


Active Ingredients/Generics

 
   triclosan
   chloroxylenol
   edetic acid